Our study built upon the prior discoveries by suggesting that circulating GFAP concentration could also serve as a promising predictor of cognitive dysfunction after ischemic stroke, which may help clinicians better understand the pathology of PSCI and further guide health care professionals in implementing targeted monitoring and personalized interventions for individuals identified as high risk. Here, GFAP is linked to ischemic stroke.